PEL

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 84241 lacs for quarter ending on 30-JUN-2010 against Rs. 82154 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 8074 lacs for the quarter ending on 30-JUN-2010 against Rs. 8510 lacs for the quarter ending on 30-JUN-2009.

Piramal Healthcare Limited has submitted to the Exchange a brief summary of the business transacted at the AGM held on July 09, 2010: 1)The Audited Accounts for the year ended March 31, 2010 were adopted; 2)Dividend at Rs. 5.40 per equity share of Rs.2/- (i.e. @ 270%) on 20,90,13,144 Equity Shares was declared for the financial year ended March 31, 2010; 3) Mr. R. A. Shah and Mr. N. Vaghul have been reappointed as Directors of the Company; 4) M/s. Price Waterhouse, Chartered Accountants, Mumbai have been reappointed as Auditors of the Company. Special Business: a) Special Resolution for paymen

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated July 14, 2010 titled "Piramal Healthcare Limited to sell Piramal Diagnostic Services Private Limited to Super Religare Laboratories".

Piramal Healthcare Limited has submitted to the Exchange a copy of the Resolution passed by the shareholders by voting by means of Postal Ballot under Section 192A of The Companies Act, 1956, on June 25, 2010.

Piramal Healthcare Limited has informed the Exchange regarding the Results on Voting by Postal Ballot- both resolutions approved by overwhelming requisite majority.

Piramal Healthcare Limited has submitted to the Exchange a copy of the Notice of Annual General Meeting of the Company scheduled to be held on July 09, 2010.

Piramal Healthcare Limited has informed the Exchange regarding a Press Release dated June 22, 2010 titled "Piramal Healthcare Limited to acquire assets of BioSyntech, a biotechnology company developing novel products in regenerative medicine".

Piramal Healthcare Limited has informed the Exchange that pursuant to Section 192A read with Section 293(1)(a) of the Companies Act, 1956 (the "Act") and the Companies (Passing of the Resolution by Postal ballot) Rules, 2001 (the "Rules") and the Memorandum and Articles of Association of the Company, the Company is seeking approval to the following Ordinary Resolutions :- (1) Ordinary Resolution under section 293 (1)(a) of the Companies Act, 1956 for the sale and transfer of the Domestic Formulations Division of the Company for a total consideration of Rupee equivalent of US$ 3,720 million; (2

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 21, 2010, titled "Piramal Healthcare Limited to sell its Domestic Formulations (Healthcare Solutions) business to Abbott Laboratories".

News Verification : The media had reports that Pfizer Limited may buy a controlling stake in Piramal Healthcare Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Piramal Healthcare Limited has vide its letter inter-alia stated," We hereby confirm that there is no proposal by the Promoter for selling any stake in the Company."

Piramal Healthcare Limited has informed the Exchange that the Annual General Meeting of the Company will be held on July 09, 2010. Further the Register of Members and Share Transfer Books shall remain closed from July 01, 2010 to July 09, 2010 (both days inclusive) for the purpose of payment of Dividend. Payment of dividend would be made within 5 days from the AGM date when dividend would be declared.

Piramal Healthcare Limited has informed the Exchange regarding a press release dated May 07, 2010, titled "Piramal Healthcare reports FY2010 results; Consolidated Revenues for the year up by 11.9% to Rs. 36.7 billion, Operating Profit up by 27.5% to Rs. 7.4 billion, Net Profit up by 52.4% to Rs. 4.8 billion; Board of Directors has recommended a dividend of Rs. 5.4 per equity share of Rs. 2 (i.e. 270%)".

Piramal Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 07, 2010 has recommended dividend Rs.5.40 per equity share of face value of Rs.2/- each (i.e. @ 270%) for the financial year ended March 31, 2010.

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 94182 lacs for quarter ending on 31-MAR-2010 against Rs. 85091 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 15432 lacs for the quarter ending on 31-MAR-2010 against Rs. 11490 lacs for the quarter ending on 31-MAR-2009.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 68389 lacs for quarter ending on 31-MAR-2010 against Rs. 62297 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 11661 lacs for the quarter ending on 31-MAR-2010 against Rs. 11627 lacs for the quarter ending on 31-MAR-2009.

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 367105 lacs for year ending on 31-MAR-2010 against Rs. 328110 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 48190 lacs for the year ending on 31-MAR-2010 against Rs. 31625 lacs for the year ending on 31-MAR-2009.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 266621 lacs for year ending on 31-MAR-2010 against Rs. 233346 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 44322 lacs for the year ending on 31-MAR-2010 against Rs. 27532 lacs for the year ending on 31-MAR-2009.

Piramal Healthcare Limited has informed the Exchange regarding a press release dated April 22, 2010, titled "Piramal Healthcare Limited to acquire the Anesthetic products business of Bharat Serums And Vaccines Limited". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/pirhealth_pr_22042010.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated March 23, 2010, titled "Piramal Healthcare Limited Acquires 'i-pill', India's No 1 Emergency Contraceptive Brand from Cipla Ltd.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/pirhealth_pr_23032010.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated January 21, 2010, titled "Piramal Healthcare Reports Q3 FY2010 Results; Consolidated Revenues for the quarter up by 9.0% to Rs. 9.1 billion, Operating Profit up by 45.0% to Rs.1.8 billion, Net Profit up by 128% to Rs.1.4 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_21012010.zip target=NEW> For more details click here

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 90770 lacs for quarter ending on 31-DEC-2009 against Rs. 82833 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 13621 lacs for the quarter ending on 31-DEC-2009 against Rs. 5987 lacs for the quarter ending on 31-DEC-2008.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 70489 lacs for quarter ending on 31-DEC-2009 against Rs. 58046 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 13828 lacs for the quarter ending on 31-DEC-2009 against Rs. 3867 lacs for the quarter ending on 31-DEC-2008.

Piramal Healthcare Limited has informed the Exchange that:"The Share Transfer Agent of the Company is being changed from M/s Freedom Registry Limited (formerly known as Amtrac Management Services Limited) to M/s Link Intime India Pvt. Ltd. with effect from 1st February, 2010".

Piramal Healthcare Limited has informed the Exchange vide its letter dated December 03, 2009 that "The Board of Directors of the Company at its meeting today, approved a proposal for raising funds upto an amount of Rs. 1000 crores through an issue of equity/ equity-linked securities, subject to requisite approvals. The duly authorized Committee of Directors has been empowered to take a final decision on the pricing, mode and manner of raising such funds."

Piramal Healthcare Limited has informed the Exchange regarding a press release dated October 22, 2009, titled "Piramal Healthcare Reports Q2 FY2010 Results; Consolidated Revenues for the Quarter up by 12.4% to Rs. 10.0 billion, Operating Profit up by 26.1% to Rs.1.8 billion, Net Profit up by 44.8% to Rs.1.0 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramil_PR_22102009.zip target=NEW> For more details click h

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 182153 lacs for half year ending on 30-SEP-2009 against Rs. 158856 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 19137 lacs for the half year ending on 30-SEP-2009 against Rs. 14148 lacs for the half year ending on 30-SEP-2008.

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 99999 lacs for quarter ending on 30-SEP-2009 against Rs. 88425 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 10627 lacs for the quarter ending on 30-SEP-2009 against Rs. 7339 lacs for the quarter ending on 30-SEP-2008.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 127743 lacs for half year ending on 30-SEP-2009 against Rs. 111729 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 18833 lacs for the half year ending on 30-SEP-2009 against Rs. 12038 lacs for the half year ending on 30-SEP-2008.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 70770 lacs for quarter ending on 30-SEP-2009 against Rs. 63197 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 11422 lacs for the quarter ending on 30-SEP-2009 against Rs. 6944 lacs for the quarter ending on 30-SEP-2008.

Piramal Healthcare Limited has informed the Exchange with reference to the earlier announcement dated September 10, 2009 on Pledge of Shares - Disclosure u/s 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997 as follows: "In view of the queries being received and to avoid confusion, we wish to clarify that the total shares pledged by the entity viz. PHL Holdings Pvt Ltd (i.e.84,20,000 shares), which is one of the constituents of the Promoter Group, constitute only 8.13% of the Promoter Group Shareholding in Piramal Healthcare Limited".

Piramal Healthcare Limited has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/PIRHEALTH_LR_25082009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated July 22, 2009, titled "Piramal Healthcare Reports Q1 FY2010 Results; Consolidated Revenues up for the Quarter by 16.0% to Rs. 8.2 billion, Operating Profit up by 34.0% to Rs.1.6 billion, Net Profit up by 25.0% to Rs.851.0 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_22072009.zip target=NEW> For more details click her

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 56973 lacs for quarter ending on 30-JUN-2009 against Rs. 48912 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 7411 lacs for the quarter ending on 30-JUN-2009 against Rs. 5094 lacs for the quarter ending on 30-JUN-2008.

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 82154 lacs for quarter ending on 30-JUN-2009 against Rs. 70832 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 8510 lacs for the quarter ending on 30-JUN-2009 against Rs. 6809 lacs for the quarter ending on 30-JUN-2008.

Piramal Healthcare Limited has informed the Exchange regarding the outcome of Annual General Meeting held on June 18, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_OutcomeAGM_23062009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange that: "The name of our Share Transfer Agent has been changed from 'Amtrac Management Services Limited' to 'Freedom Registry Limited' with effect from April 16, 2009".

Piramal Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on April 24, 2009 has fixed the date for the Annual General Meeting of the Company on June 18, 2009. Further the Register of Members and Share Transfer Books shall remain closed from June 9, 2009 to June 18, 2009 (both days inclusive) for the purpose of payment of dividend.

Piramal Healthcare Limited has informed the Exchange regarding a press release dated April 24, 2009, titled "Revenues for FY2009 up by 14.4% to Rs.32.8 billion, EBITDA (excluding FOREX impact) for the year was up by 23.7% at Rs.6.7 billion and Net Profit (excluding FOREX impact) was up by 23.5% to Rs 4.4 billion". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_24042009.zip target=NEW> For more details click here

Piramal Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on April 24, 2009 has recommended dividend @ 210% (i.e. Rs.4.20 per equity share of face value of Rs.2/- each) for the financial year ended March 31, 2009.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 233346 lacs for year ending on 31-MAR-2009 against Rs. 193002 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 27532 lacs for the year ending on 31-MAR-2009 against Rs. 30148 lacs for the year ending on 31-MAR-2008.

Piramal Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 62297 lacs for quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 11627 lacs for the quarter ending on 31-MAR-2009.

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 328110 lacs for year ending on 31-MAR-2009 against Rs. 287284 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 31625 lacs for the year ending on 31-MAR-2009 against Rs. 33378 lacs for the year ending on 31-MAR-2008.

Piramal Healthcare Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 85091 lacs for quarter ending on 31-MAR-2009 against Rs. 76787 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 11490 lacs for the quarter ending on 31-MAR-2009 against Rs. 13282 lacs for the quarter ending on 31-MAR-2008.

Piramal Healthcare Limited has informed the Exchange that "As a part of consolidation of global manufacturing assets, Piramal Healthcare has decided to discontinue operations at its manufacturing facility in Huddersfield, UK. This is an Intermediate/API site catering to the Pharma Solutions (Custom Manufacturing) business and is one of the manufacturing sites of Piramal Healthcare (UK) Ltd., the Company's wholly-owned subsidiary in the UK. In 2005, Piramal Healthcare acquired Avecia Pharmaceuticals which was then renamed as NPIL Pharmaceuticals (UK) Ltd. (now known as Piramal Healthcare (UK) L

Piramal Healthcare Limited has informed the Exchange that Ms Nandini Piramal has been appointed as an Executive Director on the Board of the Company. Ms.Nandini Piramal is the daughter of Mr. Ajay Piramal and Dr. Swati Piramal and belongs to the Promoter Group. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/piramal_Appoint_01042009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated February 28, 2009 titled "Piramal Healthcare Limited Completes Acquisition of Minrad International, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_PR_02032009.zip target=NEW> For more details click here.</a>

News Verification : The media had reports that Sanofi-Aventis may buy a substantial stake in the company. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Piramal Healthcare Limited has vide its letter inter-alia stated,"We would like to clarify that the promoter has no intention to dilute current ownership levels."

Piramal Healthcare Limited has informed the Exchange that "The Company clarifies that speculation in certain sections of the media about a potential sale of the company is totally unfounded". Further, the Company has submitted to the Exchange a press statement in this regard. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/pirhealth_PR_09022009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated January 28, 2009, titled "Piramal Healthcare Limited Acquires U.S. Inhalation Anesthetic Gas Distribution Business of RxElite, Inc.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/piramal_pr_28012009.zip target=NEW> For more details click here.</a>

Piramal Healthcare Limited has informed the Exchange regarding a press release dated January 22, 2009, titled "Piramal Healthcare reports Q3 FY2009 results; Consolidated revenues for the quarter up by 14.9% to Rs. 8.3 billion, Operating profit (excluding FOREX impact) up by 40.6% to Rs. 1.6 billion, Net Profit (before FOREX impact) up by 29.3% to Rs. 918.9 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Piramal_P